Boothbay Fund Management »

C4 Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.4M 736k 4.67
2021-03-31 $445k 12k 37.00
2020-12-31 $537k 16k 33.14

More positions owned by Boothbay Fund Management

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines Call Option (RVMD)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Invesco Exch Traded Fd Tr Ii Kbw Bk Etf Call Option (KBWB)
Tesla Motors Call Option (TSLA)
Vaxcyte (PCVX)
Constellation Brands Cl A Call Option (STZ)
Apple Call Option (AAPL)
Advanced Micro Devices Call Option (AMD)
Cornerstone Strategic Value (CLM)
Liquidia Corporation Com New (LQDA)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)

View all positions for Boothbay Fund Management

Top funds holding C4 Therapeutics

Morgan Stanley
RA Capital Management
BlackRock
Squadron Capital Management
Lynx1 Capital Management
Bain Capital Life Sciences Investors
Jpmorgan Chase & Co
Vanguard Capital Management
Citadel Advisors
Goldman Sachs Group
Daniel D. Thurber
Two Sigma Investments
Soleus Capital Management
Silverarc Capital Management
Bank of America Corporation

View all funds holding C4 Therapeutics